AlphaGrep UK’s Exelixis EXEL Stock Holding History

AlphaGrep UK’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-4,770	Closed	-$260K	–	826
2026 Q2	$260K	Sell	4,770 -3,071	-39%	-$150K	0.08%	565
2026 Q1	$336K	Sell	7,841 -7,045	-47%	-$303K	0.1%	457
2025 Q4	$652K	Buy	+14,886	New	+$616K	0.22%	120

Other funds holding EXEL

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $33.9B AUM 47.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

AlphaGrep UK's EXEL Position: Q3 2026 in Review

AlphaGrep UK sold out of Exelixis (EXEL) in Q3 2026, closing a stake of 4,770 shares — an estimated $260K sold.

AlphaGrep UK first reported a position in EXEL in Q4 2025 and held it in 3 quarters. The position peaked at $652K in Q4 2025. 637 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.

AlphaGrep UK reported no remaining Exelixis position as of Q3 2026 after selling out during the quarter.
AlphaGrep UK sold 4,770 Exelixis shares in Q3 2026, an estimated $260K.
AlphaGrep UK first reported a position in Exelixis in Q4 2025 and held it in 3 quarters.
AlphaGrep UK's Exelixis position peaked at $652K in Q4 2025.
637 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.